| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 08/17/2006 | WO2006086172A1 Cci-779 polymorph and use thereof |
| 08/17/2006 | WO2006085212A2 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv |
| 08/17/2006 | WO2006021213A3 Vasopressin v1a antagonists |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/17/2006 | US20060183759 Tissue transglutaminase inhibitors |
| 08/17/2006 | US20060183734 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 08/17/2006 | US20060179585 Sulfonamide derviatives of polycyclic dyes used for analytical applications |
| 08/17/2006 | CA2595766A1 Cci-779 polymorph and use thereof |
| 08/16/2006 | EP1689754A1 42-o-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| 08/16/2006 | EP1689746A2 A process for aqueous milling of quinacridone pigments |
| 08/16/2006 | EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder |
| 08/16/2006 | CN1820011A Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 08/16/2006 | CN1269823C 3,7-diazabicyclo [3.3.1] for mulations as anti arhythmiccompounds |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269818C Lactam compounds and medicinal use thereof |
| 08/16/2006 | CN1269817C Dehalogeno compounds |
| 08/15/2006 | US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 08/15/2006 | US7091360 Reacting nitrogen compounds such as benzoxazole, with grignard reagents to form chemical intermediates used to form cysteine protease inhibitors |
| 08/15/2006 | US7091338 An ion-containing compound is admixed with macromolecular crown ether or derivatives to form an extractant/ion complex, and the predetermined extractant/ion complex is separated from the diluent by using the new phase affinity |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091211 3-(aryl or heteroaryl)-4-((spiropiperidin-1-yl)alkyl)cyclopentyl compounds and stereisomers, used for prevention of lymphadenopathy associated virus infection, and delaying the onset of aquired immune deficiency syndrome |
| 08/15/2006 | CA2161783C Ampa antagonists and a method of treatment therewith |
| 08/10/2006 | WO2006083486A1 Amorphous tacrolimus and preparation thereof |
| 08/10/2006 | WO2006083130A1 Amorphous taclolimus solid dispersion having an enhanced solubility and pharmaceutical composition comprising same |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | US20060178393 1H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | CA2588480A1 Amorphous tacrolimus and preparation thereof |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1687314A1 PREPARATION OF 1-AZA-2-OXA-DIBENZO [e,h] AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 08/09/2006 | EP1687296A1 Antibacterial aminoquinazolidinedione derivatives |
| 08/09/2006 | EP1687283A2 Method and composition useful for determining fk 506 |
| 08/09/2006 | EP1441737B1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
| 08/09/2006 | CN1268340C Pharmaceutical composition comprising condensed indole compound |
| 08/08/2006 | US7087778 synthesis of a 2-(2,3,4-trihalogenoanilino)propionic acid by treating trihaloaniline or trihalonitrobenzene with a metal catalyst and dehydrating agent; chemical intermediate for levofloxacin |
| 08/08/2006 | US7087756 6-(4-Dimethylaminomethyl-phenyl)-3-phenyl-5H-isoxazolo[4,5-c]pyridine-4-one and 6-[4-(2-Methoxy-ethoxymethyl)-phenyl]-5-methyl-3-phenyl-5H-isoxazolo[4,5-c]pyridin-4-one; use treating Parkinson's disease |
| 08/08/2006 | US7087744 Comprises azamethine/nucleic acid complex; reverse transcription; transferases |
| 08/08/2006 | US7087730 Fiber-reactive azo dyes, their preparation and their use |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087601 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia |
| 08/08/2006 | US7087595 Antihistaminic spiro compounds |
| 08/03/2006 | WO2006081264A1 Antibacterial agents |
| 08/03/2006 | WO2006081179A1 Antibacterial agents |
| 08/03/2006 | WO2006065480A3 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 08/03/2006 | WO2006061417A3 Macrocyclic quinazole derivatives and their use as mtki |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173033 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 08/03/2006 | US20060173030 Antitumoral analogs of lamellarins |
| 08/03/2006 | US20060172999 2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-phenyl-tetrahydropyran-4-yl]methyl-2-oxa-8-aza-spiro[4,5]decan-4-ol; neurokinin 1 (NK-1) receptor antagonists; antidepressant, anxiolytic, analgesic, antiinflammatory agent; migraine, emesis or postherpetic neuralgia |
| 08/03/2006 | US20060172995 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/02/2006 | EP1685137A2 Particle-forming compositions containing fused pyrrolocarbazoles |
| 08/02/2006 | EP1684754A1 Hmg-coa reductase inhibitors and method |
| 08/02/2006 | CN1267435C New process for prepn. of oxabispidines |
| 08/01/2006 | US7084169 Aminoalkoxyindoles and methods of use |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 07/27/2006 | WO2006078865A2 Direct racemization of indole derivatives |
| 07/27/2006 | WO2006078846A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 07/27/2006 | WO2006078317A1 Substituted quinobenzoxazine analogs and methods of using thereof |
| 07/27/2006 | WO2005020894A3 Rifamycin analogs and uses thereof |
| 07/27/2006 | US20060167259 Direct racemization of indole derivatives |
| 07/27/2006 | US20060167246 (E)-3-[4-({1-[(11-cyclohexyl-8-methoxy-4,5-dihydro-6-oxa-1-thia-3b-azabenzo[e]cyclopenta[a]azulene-2-carbonyl)amino]cyclobutanecarbonyl}amino)phenyl]acrylic acid; RNA-dependent RNA polymerase inhibitory activity; hepatitis C |
| 07/27/2006 | US20060167067 Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| 07/27/2006 | US20060167039 Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 07/27/2006 | US20060167035 Quinoline derivative, its use, production and pharmaceutical agents containing the latter |
| 07/27/2006 | US20060167030 Sulfonamido-macrocycles and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof |
| 07/27/2006 | US20060167029 pyridine or pyrimidine thieno(2,3-e)pyrimidine tricyclic compounds; metabotropic glutamate receptor antagonist; analgesic, anxiolytic agent: pain, migraine, urinary incontinence; neurodegenerative diseases: Alzheimer's disease |
| 07/27/2006 | US20060166980 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 07/27/2006 | US20060166979 for prophylaxis and treatment of atrial and ventricular arrhythmias |
| 07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 07/27/2006 | US20060166977 Antibacterial agents |
| 07/27/2006 | US20060166971 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 07/27/2006 | US20060166829 N-Heterocycl phenyl-substituted cyclic ketoenols |
| 07/27/2006 | CA2834033A1 Methods for the production of ansamitocins |
| 07/27/2006 | CA2593166A1 Mitotic kinesin inhibitors |
| 07/27/2006 | CA2591948A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 07/27/2006 | CA2575547A1 Substituted quinobenzoxazine analogs and methods of using thereof |
| 07/26/2006 | EP1682556A2 Polymorphous forms of rifaximin as antibiotics |
| 07/26/2006 | EP1682555A1 Macrocyclic kinase inhibitors |
| 07/26/2006 | EP1682554A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 07/26/2006 | EP1682550A1 Substituted naphthyridinone derivatives |
| 07/26/2006 | EP1682521A1 Macrocyclic lactams and pharmaceutical use thereof |
| 07/26/2006 | EP1682502A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
| 07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/26/2006 | CN1809576A Antiparasitic terpene alkaloids |
| 07/26/2006 | CN1809347A Selective spirocyclic glucocorticoid receptor modulators |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/25/2006 | US7081453 Compounds for treating impaired fundic relaxation |
| 07/25/2006 | CA2168921C 1,6-naphthyridonecarboxylic acid derivatives |
| 07/20/2006 | WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 07/20/2006 | US20060160886 Chemical compounds |